glp 1 efficacy comparison Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Comparative efficacy of glucagon-like peptide

(1) In addition to this natural synthetization of L-carnitine, you can also get it from dietary sources such as red meat and dairy products

Sadd and Siva-Jothy 2006

They noted that a Dexcom survey found that 80% of polled physicians would only feel comfortable taking a patient off GLP-1s without losing the benefits made if they were on a CGM

Target 25-OH D 40 to 60 ng/mL, serum calcium within 8.5 to 10.2 mg/dL reference range, PTH within normal limits

Low energy availability from under-eating is a more common cause of performance decline on these medications than most people realize

Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex